RANITIDINE

Drugs in Pregnancy and Lactation.

Welcome to Pregnancy Without Pounds

You absolutely DO NOT have to pack on extra pregnancy weight.
before and after birth photos before and after birth photos

7 Months Pregnant

6 Days After Birth

Discover the secrets that most pregnant women will never know about pregnancy. Inside you'll learn...
  • How to avoid unwanted excess pounds (for a healthy pregnancy and baby!).
  • Exactly which pregnancy exercises get you fit and toned.
  • How to have an easy labor and quick recovery.
  • Exactly what you need to do now to lose weight quickly after delivery.
  • Secrets to minimize stretch marks and cellulite.
  • And you'll also get a FREE subscription to Michelle Moss's exclusive Pregnancy Secrets e-Letter...

Get a FREE subscription to my Pregnancy Exercise, Diet and Beauty Tips Newsletter sent to you each week.

Sign In!
.


Name: RANITIDINE
Class: Gastrointestinal Agent (Antisecretory)
Risk Factor:    BM

Fetal Risk Summary

Ranitidine is a competitive, reversible inhibitor of histamine H2-receptors used in treatment and maintenance of patients with duodenal or gastric ulcers, pathologic hypersecretory conditions such as Zollinger-Ellison syndrome, and gastroesophageal reflux disease (GERD).

Reproduction studies with ranitidine in rats and rabbits at doses up to 160 times the human dose have revealed no evidence of impaired fertility or fetal harm (1,2 and 3). In contrast to the controversy surrounding cimetidine, ranitidine apparently has no antiandrogenic activity in humans (4) or in animals (5,6) (see also Cimetidine).

Ranitidine crosses the placenta at term to produce mean fetal:maternal ratios after 50 mg IV and 150 mg orally of 0.9 and 0.38, respectively (7,8 and 9).

In a surveillance study of Michigan Medicaid recipients involving 229,101 completed pregnancies conducted between 1985 and 1992, 516 newborns had been exposed to ranitidine during the 1st trimester (F. Rosa, personal communication, FDA, 1993). A total of 23 (4.5%) major birth defects were observed (22 expected). Specific data were available for six defect categories, including (observed/expected) 6/5 cardiovascular defects, 1/1 oral clefts, 1/0.5 spina bifida, 1/1 polydactyly, 0/1 limb-reduction defects, and 1/1 hypospadias. These data do not support an association between the drug and congenital defects.

The drug has been used alone and in combination with antacids to prevent gastric acid aspiration (Mendelson's syndrome) before vaginal delivery or cesarean section (7,8,9,10,11,12 and 13). No effect was observed in the frequency and strength of uterine contractions, in fetal heart rate pattern, or in Apgar scores (7). Neonatal gastric acidity was not affected at 24 hours. No problems in the newborn attributable to ranitidine were reported in these studies.

Ranitidine has been studied for its effectiveness in alleviating the symptoms of gastroesophageal reflux (heartburn) during pregnancy (14,15 and 16). A twice-daily dosage regimen of ranitidine was effective for this indication (14,15 and 16), including in those cases resistant to antacids alone (16). Ranitidine was also effective in controlling acid secretion in pregnant women with Zollinger-Ellison syndrome (17).

A 1996 prospective cohort study compared the pregnancy outcomes of 178 women who were exposed during pregnancy to histamine H2 blockers with 178 controls matched for maternal age, smoking, and heavy alcohol consumption (18). All of the women had contacted a Teratology Information Service concerning gestational exposure to H2-receptor antagonists (subjects) or nonteratogenic or nonfetotoxic agents (controls). Among subjects (mean daily dose in parentheses), 71% took ranitidine (258 mg), 16% cimetidine (487 mg), 8% famotidine (32 mg), and 5% nizatidine (283 mg). There were no significant differences between the outcomes of subjects and controls in terms of live births, spontaneous and elective abortions, gestational age at delivery, delivery method, birth weight, infants small for gestational age, or major malformations. Among subjects, there were 3 birth defects (2.1%) among the 142 exposed to H2 blockers in the 1st trimester: one each of atrial septal defect, ventricular septal defect, and tetralogy of Fallot. There were 5 birth defects (3.0%) among the 165 exposed anytime during pregnancy. For controls, the rates of defects were 3.5% (1st trimester) and 3.1% (anytime). There were also no differences between the groups in neonatal health problems and developmental milestones, but two children (one subject and one control) were diagnosed as developmentally delayed. The investigators concluded that 1st trimester exposure to histamine H2 blockers did not represent a major teratogenic risk (18).

Data from the Swedish Medical Birth Registry were presented in 1998 (19). A total of 553 infants (6 sets of twins) were delivered from 547 women who had used acid-suppressing drugs early in pregnancy. A number of other pharmaceutical agents, identified only by drug category, were also used by these women. Seventeen infants with birth defects were identified (3.1%; 95% confidence interval [CI] 1.8–4.9) compared with the crude malformation rate of 3.9% in the Registry. The odds ration (OR) for a congenital malformation, stratified for birth year, maternal age, parity, and smoking was 0.72 (95% CI 0.41–1.24). The OR for malformations after proton pump blocker exposure was 0.91 (95% CI 0.45–1.84) compared with 0.46 (95% CI 0.17–1.20) for H2-receptor antagonists (OR 0.86, 95% CI 0.33–2.23; p=0.13). Of the 17 infants with birth defects, 10 had been exposed to proton pump blockers, 6 to H2 antagonists, and 1 to both classes of drug. Ranitidine was the only acid-suppressing drug exposure for 156 infants. Twenty other offspring were exposed in utero to ranitidine combined either with famotidine (2 infants) or with omeprazole (18 infants). Six birth defects (3.8%) were observed in the group where ranitidine was the only acid-suppressing agent used. The defects were cerebral arteriovenous malformation, unspecified cardiac defect, hydronephrosis, undescended testicle, hypospadias, and unstable hip. Hypospadias was observed in a newborn exposed to a combination of ranitidine and omeprazole (19).

Two databases, one from England and the other from Italy, were combined for a study published in 1999 that was designed to assess the incidence of congenital malformations in women who had received a prescription during the 1st trimester for an acid-suppressing drug (ranitidine, cimetidine, and omeprazole) (20). Nonexposed women were selected from the same databases to form a control group. Spontaneous abortions and elective abortions (except two cases for anomalies that were grouped with stillbirths) were excluded from the analysis. Stillbirths were defined as any pregnancy loss occurring at 28 weeks' gestation or later. Ranitidine was taken in 322 pregnancies, resulting in 330 live births (29 [8.8%] premature), 2 stillbirths, and 1 neonatal death. Twenty (6.1%) of the newborns had a congenital malformation (shown by system): central nervous system (spina bifida/hydrocephaly), craniofacial (cleft palate only; asymmetric skull/plagiocephaly; tongue tie), eye (Duane's eye syndrome), cardiac (septal defect; anomaly of cardiac valve); musculoskeletal (dysplastic hip/dislocation/clicking hip N=3; syndactyly; sacral sinus); genital and urinary (undescended testes N=2; congenital hydrocele/inguinal hernia N=2; ovarian cyst); multiple (pyloric stenosis and talipes equinovarus); and two genetic anomalies (Hallerman-Streiff and Down's syndromes). In addition, two newborns were small for gestational age and nine had a small head circumference for gestational age. In comparison, the outcomes of 1,547 nonexposed pregnancies included 1,560 live births (115 [7.4%] premature), 15 stillbirths (includes 2 elective abortions for anomalies), and 10 neonatal deaths. Sixty-four (4.1%) of the newborns had malformations involving the following: central nervous system (N=2), head/face (N=13), eye (N=2), heart (N=7), muscle/skeletal (N=13), genital/urinary (N=18), gastrointestinal (N=2), and those of polyformation (N=3) or known genetic defects (N=4). There were 21 newborns that were small for gestational age and 78 had a small head circumference for gestational age. The relative risk of malformation (adjusted for mother's age and prematurity) associated with ranitidine was 1.5 (95% CI 0.9–2.6), with cimetidine 1.3 (95% CI 0.7–2.6), and with omeprazole 0.9 (95% CI 0.4–2.4) (20).

In summary, the absence of teratogenicity or toxicity in animals and the available human pregnancy data indicate that ranitidine is not a major teratogen. Because it has no antiandrogenic activity in animals or nonpregnant humans, ranitidine may be a safer choice than cimetidine for chronic use during pregnancy. The antiandrogenic activity of cimetidine, however, has not been observed or studied following in utero exposure (see Cimetidine).

Breast Feeding Summary

Following a single oral dose of 150 mg in six subjects, ranitidine milk concentrations increased with time, producing mean milk:plasma ratios at 2, 4, and 6 hours of 1.9, 2.8, and 6.7, respectively (21). The effect of these concentrations on the nursing infant is not known. Ranitidine decreases gastric acidity, but this effect has not been studied in nursing infants. However, cimetidine, an agent with similar activity, is considered to be compatible during breast feeding by the American Academy of Pediatrics (22).

References

  1. Product information. Zantac. Glaxo Wellcome, 2000.
  2. Higashida N, Kamada S, Sakanove M, Takeuchi M, Simpo K, Tanabe T. Teratogenicity studies in rats and rabbits. J Toxicol Sci 1983;8:101–50. As cited in Shepard TH. Catalog of Teratogenic Agents. 6th ed. Baltimore, MD: Johns Hopkins University Press, 1989:550.
  3. Higashida N, Kamada S, Sakanove M, Takeuchi M, Simpo K, Tanabe T. Teratogenicity studies in rats and rabbits. J Toxicol Sci 1984;9:53–72. As cited in Shepard TH. Catalog of Teratogenic Agents. 6th ed. Baltimore, MD: Johns Hopkins University Press, 1989:550.
  4. Wang C, Wong KL, Lam KC, Lai CL. Ranitidine does not affect gonadal function in man. Br J Clin Pharmacol 1983;16:430–2.
  5. Parker S, Udani M, Gavaler JS, Van Thiel DH. Pre- and neonatal exposure to cimetidine but not ranitidine adversely affects adult sexual functioning of male rats. Neurobehav Toxicol Teratol 1984;6:313–8.
  6. Parker S, Schade RR, Pohl CR, Gavaler JS, Van Thiel DH. Prenatal and neonatal exposure of male rat pups to cimetidine but not ranitidine adversely affects subsequent adult sexual functioning. Gastroenterology 1984;86:675–80.
  7. McAuley DM, Moore J, Dundee JW, McCaughey W. Preliminary report on the use of ranitidine as an antacid in obstetrics. Ir J Med Sci 1982;151:91–2.
  8. McAuley DM, Moore J, McCaughey W, Donnelly BD, Dundee JW. Ranitidine as an antacid before elective caesarean section. Anaesthesia 1983;38:108–14.
  9. McAuley DM, Moore J, Dundee JW, McCaughey W. Oral ranitidine in labour. Anaesthesia 1984;39:433–8.
  10. Gillett GB, Watson JD, Langford RM. Prophylaxis against acid aspiration syndrome in obstetric practice. Anesthesiology 1984;60:525.
  11. Mathews HML, Wilson CM, Thompson EM, Moore J. Combination treatment with ranitidine and sodium bicarbonate prior to obstetric anaesthesia. Anaesthesia 1986;41:1202–6.
  12. Ikenoue T, Iito J, Matsuda Y, Hokanishi H. Effects of ranitidine on maternal gastric juice and neonates when administered prior to caesarean section. Aliment Pharmacol Ther 1991;5:315–8.
  13. Rout CC, Rocke DA, Gouws E. Intravenous ranitidine reduces the risk of acid aspiration of gastric contents at emergency cesarean section. Anest Analg 1993;76:156–61.
  14. Larson J, Patatanian E, Miner P, Rayburn W, Robinson M. Double-blind, placebo controlled study of ranitidine (Zantac) for gastroesophageal reflux symptoms during pregnancy (abstract). Am J Obstet Gynecol 1997;176:S23.
  15. Larson JD, Patatanian E, Miner PB Jr, Rayburn WF, Robinson MG. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstet Gynecol 1997;90:83–7.
  16. Rayburn W, Liles E, Christensen H, Robinson M. Antacids vs. antacids plus non-prescription ranitidine for heartburn during pregnancy. Int J Gynaecol Obstet 1999;66:35–7.
  17. Stewart CA, Termanini B, Sutliff VE, Corleto VD, Weber HC, Gibril F, Jensen RT. Management of the Zollinger-Ellison syndrome in pregnancy. Am J Obstet Gynecol 1997;176:224–33.
  18. Magee LA, Inocencion G, Kamboj L, Rosetti F, Koren G. Safety of first trimester exposure to histamine H2 blockers. A prospective cohort study. Dig Dis Sci 1996;41:1145–9.
  19. Kallen B. Delivery outcome after the use of acid-suppressing drugs in early pregnancy with special Reference to omeprazole. Br J Obstet Gynaecol 1998;105:877–81.
  20. Ruigomez A, Rodriguez LAG, Cattaruzzi C, Troncon MG, Agostinis L, Wallander MA, Johansson S. Use of cimetidine, omeprazole, and ranitidine in pregnant women and pregnancy outcomes. Am J Epidemiol 1999;150:476–81.
  21. Riley AJ, Crowley P, Harrison C. Transfer of ranitidine to biological fluids: milk and semen. In Misiewicz JJ, Wormsley KG, eds. Proceedings of the 2nd International Symposium on Ranitidine. London. Oxford: Medicine Publishing Foundation, 1981:78–81.
  22. Committee on Drugs, American Academy of Pediatrics. The transfer of drugs and other chemicals into human milk. Pediatrics 1994;93:137–50.

Index

Q&A about Ranitidine

tess
ranitidine?
im having an ear problem for more than two months. I went to the doctor and he gave me some medicine. it was ranitidine. but when i read the bottle, it says that is for ulcers and acid in the stomach. the stomach has NOTHING to do with my ear at all. is there any answer why he prescribe me this medicine?
richdanc...
sounds like you have got the wrong pills, I took those same pills for 10 yrs for a stomach ulcer, go back to the doctor
smurphy
What would happen to someone with a history of kidney stones, who took Zantac/Ranitidine for over 2 years?
I am interested to know whether taking Zantac/Ranitidine long term (300mg every day for over 2 years) is likely to have an effect on the condition of a persons kidneys, especially if they had a history of stones. Should a person with kidney stones even be taking Zantac? Is there any known evidence of Zantac causing kidney damage?
cdsfhc20...
Ranitidine is a very safe medicine and it is documented to be safe for use over long periods of time. Taking zantac does not cause kidney stones or kidney damage. If you have chronic heartburn or gerd and the ranitidine is working I wouldnt worry about discontinuing it, if it is not working or you dont have these conditions talk to your doctor about if you need it or not or if you need another medicine
J
Differences in indications for IV and oral ranitidine or PPI. Will IV affect the GI tract less?
I am interested in rantidine for other H1 properties than heartburn. Same with cemitidine. Thanks.
W W D
The only real difference between IV and PO is for people who can't take PO, as those who are actively vomiting.

None of these seems to affect GI bleeding, but the H2 blockers seem to be a pretty good adjuvant treatment for allergic problems like hives and are occasionally used to premedicate in, as an example, IV contrast radiography where there's a risk of anaphylactoid reactions, as part of a cocktail. PPI's, of course, don't make sense in these applications.

Some people also use them to decrease gastric acidity pre-operatively as a prophylactic for reflux/aspiration.
Caiden & Levi's Mommy
How do you get your baby to take Zantac (Ranitidine) for reflux?
My 4 month old was put on Zantac for reflux. We gave him his first dose this morning, and he spit it all out. I gave it to him from a syringe, in his cereal, and mixed with juice in a bottle...he would not swallow any of it. Any suggestions on how to get him to take it? Thanks!
God Bless our Troops!
If my daughter did that, I would put it in bottle with a bit of formula or breastmilk and shake it up and give it to her.

They also have these things that you give them medicine with, they have a nipple on the top and you put the medicine in the bottom... I dont remember what they are called. You can buy them at walmart or walgreens. You give it to them just like a bottle and they suck it right out.
Wonderer
Ranitidine in the morning, beer in the evening?
If I had a ranitidine (Zantac) in the morning, can I have one or two beers in the evening?
aWellWis...
There is no interaction.

And yeah, inspect. is right, twice a day schedule is- morning--evening. Once a day is usually at bedtime.

Good luck!
Cheese Burger
Does anyone know what the long term affects of using the prescription drug Ranitidine are?
Or where I can go to find out? I can't seem to find anything about this particular drug. My dad has been taking it regularly for the past 3 months, he gets it over the counter from the pharmacy but I have just discovered that you shouldn't buy a second pack without consulting a Doctor it says so in the pack leaflet. He takes it for very bad heart burn. Does anyone know if this drug is dangerous with long term use? it doesn't say on the leaflet other then known side effects from normal usage.
benandga...
The reason it says not to buy a second pack withoug consulting your doctor is because the acid that is causing your dads heartburn could be burning his esophagus. He may need a stronger prescription that not only controls the heartburn but also helps repair the esophagus.

Ranitidine has been effective in preventing ulcer recurrence when given in low doses for prolonged periods of time. In doses higher than that used in ulcer treatment, ranitidine has been helpful in treating heartburn and in healing ulcer and inflammation of the esophagus resulting from acid reflux (reflux esophagitis).

Minor side effects include constipation, diarrhea, fatigue, headache, insomnia, muscle pain, nausea, and vomiting. Major side effects are rare; they include: agitation, anemia, confusion, depression, easy bruising or bleeding, hallucinations, hair loss, irregular heartbeat, rash, visual changes, and yellowing of the skin or eyes.

You really should convince him to go to the doctor.
nonie101...
How long will it take to heal a gastritis diseases. Will Ranitidine 150 mg works?
My son had been suffering from stomach disorders and bloatedness since 2002. Please help me.
petrobom...
it depends on what kind of gastritis disease he has. the idea with ranitidine is to lower the production of stomach acid so that your own body can heal itself naturally. there are no drugs out there that will actually heal the problem itself.

in general, if the disease hasnt cleared up, the dr. may put your son on another class of drugs that actually work better to reduce stomach acid. the problem with gastritis disease is that they can cause ulceration and infections if not treated